Stifel initiates Immunome stock coverage with Hold rating at $24
AI Summary
Stifel initiated coverage of Immunome stock with a Hold rating and a $24 price target. The brief report provides no additional rationale or company details.
Stifel initiated coverage of Immunome stock with a Hold rating and a $24 price target. The brief report provides no additional rationale or company details.
Punch Nigeria —
The Hill —
Globo —
Vanguard Nigeria —
Yahoo Sports —
Container News —